Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jiejin Zhu, Wanshu Li, Changcheng Shi & Qingyu Li. (2022) A pharmacoeconomic evaluation of the pharmacotherapeutic options for painful diabetic neuropathy. Expert Opinion on Pharmacotherapy 23:5, pages 551-559.
Read now
Read now
Bill McCarberg, Yvonne D’Arcy, Bruce Parsons, Alesia Sadosky, Andrew Thorpe & Regina Behar. (2017) Neuropathic pain: a narrative review of etiology, assessment, diagnosis, and treatment for primary care providers. Current Medical Research and Opinion 33:8, pages 1361-1369.
Read now
Read now
Simone Critchlow, Matthew Hirst, Ron Akehurst, Ceri Phillips, Zoe Philips, Will Sullivan & Will C.N. Dunlop. (2017) A systematic review of cost-effectiveness modeling of pharmaceutical therapies in neuropathic pain: variation in practice, key challenges, and recommendations for the future. Journal of Medical Economics 20:2, pages 129-139.
Read now
Read now
Jordan B King, Marisa B Schauerhamer & Brandon K Bellows. (2015) A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain. Therapeutics and Clinical Risk Management 11, pages 1163-1175.
Read now
Read now
Brandon K. Bellows, Arati Dahal, Tianze Jiao & Joseph Biskupiak. (2012) A Cost-Utility Analysis of Pregabalin Versus Duloxetine for the Treatment of Painful Diabetic Neuropathy. Journal of Pain & Palliative Care Pharmacotherapy 26:2, pages 153-164.
Read now
Read now
Fernando Carlos, Jocelyn Ramírez-Gámez, Héctor Dueñas, Rosa María Galindo-Suárez & Elisa Ramos. (2012) Economic evaluation of duloxetine as a first-line treatment for painful diabetic peripheral neuropathy in Mexico. Journal of Medical Economics 15:2, pages 233-244.
Read now
Read now
Lindsay Zilliox & James W Russell. (2010) Maintaining efficacy in the treatment of diabetic peripheral neuropathic pain: role of duloxetine. Diabetes, Metabolic Syndrome and Obesity 3, pages 7-17.
Read now
Read now
Mitra Tavakoli & Rayaz A Malik. (2008) Management of painful diabetic neuropathy. Expert Opinion on Pharmacotherapy 9:17, pages 2969-2978.
Read now
Read now
Articles from other publishers (20)
Solomon Tesfaye, Gordon Sloan, Jennifer Petrie, David White, Mike Bradburn, Tracey Young, Satyan Rajbhandari, Sanjeev Sharma, Gerry Rayman, Ravikanth Gouni, Uazman Alam, Steven A Julious, Cindy Cooper, Amanda Loban, Katie Sutherland, Rachel Glover, Simon Waterhouse, Emily Turton, Michelle Horspool, Rajiv Gandhi, Deirdre Maguire, Edward Jude, Syed Haris Ahmed, Prashanth Vas, Christian Hariman, Claire McDougall, Marion Devers, Vasileios Tsatlidis, Martin Johnson, Didier Bouhassira, David L Bennett & Dinesh Selvarajah. (2022) Optimal pharmacotherapy pathway in adults with diabetic peripheral neuropathic pain: the OPTION-DM RCT. Health Technology Assessment 26:39, pages 1-100.
Crossref
Crossref
Tianyu Xue, Xin Zhang, Yiwen Xing, Shuhan Liu, Lijun Zhang, Xun Wang & Min Yu. (2021) Advances About Immunoinflammatory Pathogenesis and Treatment in Diabetic Peripheral Neuropathy. Frontiers in Pharmacology 12.
Crossref
Crossref
Emma Gray, Xin Ye, Yen-Feng Wang & Shuu-Jiun Wang. (2021) Cost-Effectiveness of Mirogabalin for the Treatment of Diabetic Peripheral Neuropathic Pain in Taiwan. Value in Health Regional Issues 24, pages 148-156.
Crossref
Crossref
Maher R Khdour. (2020) Treatment of diabetic peripheral neuropathy: a review. Journal of Pharmacy and Pharmacology 72:7, pages 863-872.
Crossref
Crossref
Natalia Ruiz-Negrón, Jyothi Menon, Jordan B. King, Junjie Ma & Brandon K. Bellows. (2019) Cost-Effectiveness of Treatment Options for Neuropathic Pain: a Systematic Review. PharmacoEconomics 37:5, pages 669-688.
Crossref
Crossref
Dong-mei Zhou, Ying Zhuang, Wen-jun Chen, Wei Li & Bei Miao. (2018) Effects of Duloxetine on the Toll-Like Receptor 4 Signaling Pathway in Spinal Dorsal Horn in a Rat Model of Diabetic Neuropathic Pain. Pain Medicine 19:3, pages 580-588.
Crossref
Crossref
Brandon K. Bellows, Richard E. Nelson, Gary M. Oderda & Joanne LaFleur. (2016) Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine. Pain 157:1, pages 203-213.
Crossref
Crossref
Cathelijne J.M. Alleman, Kirsten Y. Westerhout, Marja Hensen, Colette Chambers, Malcolm Stoker, Stephen Long & Floortje E. van Nooten. (2015) Humanistic and economic burden of painful diabetic peripheral neuropathy in Europe: A review of the literature. Diabetes Research and Clinical Practice 109:2, pages 215-225.
Crossref
Crossref
Fernando Carlos, Luis Espejel, Diego Novick, Rubén López & Daniel Flores. (2015) Duloxetina para el tratamiento de la neuropatía diabética periférica dolorosa en Venezuela: evaluación económica. Medwave 15:08, pages e6265-e6265.
Crossref
Crossref
Saad Javed, Ioannis N. Petropoulos, Uazman Alam & Rayaz A. Malik. (2014) Treatment of painful diabetic neuropathy. Therapeutic Advances in Chronic Disease 6:1, pages 15-28.
Crossref
Crossref
Miguel Elizondo-Cano, Fernando Carlos-Rivera, Jocelyn Ramírez-Gámez & Héctor Dueñas. (2014) Evaluación económica del uso de duloxetina en el tratamiento del dolor crónico causado por osteoartritis de rodilla en el sistema privado de salud en México. PharmacoEconomics Spanish Research Articles 11:3, pages 61-72.
Crossref
Crossref
Michael PT Lunn, Richard AC Hughes & Philip J Wiffen. (2014) Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. Cochrane Database of Systematic Reviews 2015:10.
Crossref
Crossref
Kathrin Doppler & Claudia Sommer. (2012) Pharmacotherapy in patients with painful diabetic neuropathy: what do recent guidelines tell us?. Clinical Practice 9:3, pages 279-285.
Crossref
Crossref
Luis A. Pliego. (2010) Inhibidores de la recaptación de serotonina y noradrenalina en el manejo del dolor de la neuropatía diabética. Neurología Argentina 2:3, pages 180-188.
Crossref
Crossref
Roberto Vlainich, Paola Zucchi, Adriana Machado Issy & Rioko Kimiko Sakata. (2010) Evaluating the Cost of Drugs used in the Outpatient Treatment of Chronic Pain. Brazilian Journal of Anesthesiology 60:4, pages 399-405.
Crossref
Crossref
Michael PT Lunn, Richard AC Hughes & Philip J Wiffen. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. (2009) Current World Literature. Current Opinion in Supportive & Palliative Care 3:2, pages 144-151.
Crossref
Crossref
Alec B. OʼConnor. (2009) Neuropathic Pain. PharmacoEconomics 27:2, pages 95-112.
Crossref
Crossref
Mitra Tavakoli, Moaz Mojaddidi, Hassan Fadavi & Rayaz A. Malik. (2008) Pathophysiology and treatment of painful diabetic neuropathy. Current Pain and Headache Reports 12:3, pages 192-197.
Crossref
Crossref
. (2013) Duloxetine dulls the pain and the pounds for diabetic neuropathy. PharmacoEconomics & Outcomes News 547:1, pages 4-4.
Crossref
Crossref